TY  - RPRT
TI  - The Impact of SARS-CoV-2 nsp14 Proofreading on Nucleoside Antiviral Activity: Insights from Genetic and Pharmacological Investigations
AU  - Peng, J.-Y.
AU  - Lahser, F.
AU  - Warren, C.
AU  - He, X.
AU  - Murray, E.
AU  - Wang, D.
PY  - 2024
DO  - 10.1101/2024.07.24.604948
UR  - https://www.biorxiv.org/content/10.1101/2024.07.24.604948v1
ID  - 10.1101/2024.07.24.604948
ER  -